Innovative technologies are revolutionizing cancer research, driving advancements in diagnosis, treatment, and drug development. Artificial intelligence (AI) and machine learning are transforming early detection by analyzing complex imaging data and predicting treatment outcomes with greater accuracy.
Next-generation sequencing (NGS) is unlocking insights into genetic mutations, enabling personalized therapies tailored to individual cancer profiles. CRISPR-Cas9 gene editing offers groundbreaking potential by targeting and correcting genetic errors linked to cancer development.
Meanwhile, 3D bioprinting and organ-on-a-chip technologies are creating precise tumor models, accelerating drug testing while reducing reliance on traditional methods. Advances in immunotherapy, powered by deep molecular insights, are enhancing the immune system’s ability to fight cancer. These innovations are reshaping cancer research, offering hope for better treatments and improved patient outcomes.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms
Can Küçük, Dokuz Eylul University, Turkey
Title : Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma
Shayan Maqsood, Jamia Hamdard University, India